Disclaimer: The findings of the following analysis are the sole opinions of the writer and should not be considered investment advice Over the last five months, Avalanche (AVAX) has rejected higher peaks while its price took a plunge toward the $52-mark. Since then, the buyers have provoked a strong recovery, one that flipped the long-term trendline […]